Jove
Visualize
Contact Us

Related Experiment Videos

Cirrhotic cardiomyopathy.

Waleed Al Hamoudi1, Samuel S Lee

  • 1Liver Unit, University of Calgary, Calgary, Alberta, Canada.

Annals of Hepatology
|October 25, 2006
PubMed
Summary
This summary is machine-generated.

Cirrhotic cardiomyopathy, a heart condition in liver cirrhosis patients, involves hyperdynamic circulation and impaired contractility. Liver transplantation can effectively treat these cardiovascular complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendrite initiation and deflection in biaxially stressed solid electrolytes.

Nature·2026
Same author

A Gender-Based Descriptive Analysis of the Canadian Network Undertaking Against Hepatitis C (CANUHC) Cohort From 2015-2023.

Open forum infectious diseases·2026
Same author

Temporal trends in hepatic steatosis and its risk factors among young adults: A comparative cohort study.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same author

Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer.

Scientific reports·2026
Same author

Heterogeneous doping via nanoscale coating impacts the mechanics of Li intrusion in brittle solid electrolytes.

Nature materials·2026
Same author

Prevalence of cirrhotic cardiomyopathy in liver transplant candidates: Impact on pre- and post-transplant mortality.

Annals of hepatology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Liver cirrhosis presents with diverse cardiovascular abnormalities, including hyperdynamic circulation and impaired ventricular function.
  • These cardiac issues, collectively termed cirrhotic cardiomyopathy, involve structural and electrophysiological changes like QT prolongation.
  • Pathogenesis is multifactorial, involving cardiomyocyte membrane changes, altered signaling pathways, and enhanced inhibitory systems.

Purpose of the Study:

  • To review the characteristics and pathogenic mechanisms of cirrhotic cardiomyopathy.
  • To explore the role of cirrhotic cardiomyopathy in liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS) placement, and hepatorenal syndrome.
  • To discuss the therapeutic implications, particularly the role of liver transplantation.

Related Experiment Videos

Main Methods:

  • Literature review of studies on cardiovascular abnormalities in liver cirrhosis.
  • Analysis of pathogenic mechanisms underlying cirrhotic cardiomyopathy.
  • Evaluation of the impact of interventions like liver transplantation and TIPS.

Main Results:

  • Cirrhotic cardiomyopathy is characterized by increased cardiac output, decreased peripheral resistance, impaired contractility, and QT prolongation.
  • It significantly contributes to cardiac dysfunction post-liver transplantation or TIPS and in hepatorenal syndrome.
  • Liver transplantation improves hemodynamic dysfunctions, including cirrhotic cardiomyopathy and QT interval prolongation.

Conclusions:

  • Cirrhotic cardiomyopathy is a distinct clinical entity in liver cirrhosis with significant implications for patient outcomes.
  • Liver transplantation is the definitive treatment for cardiovascular complications associated with liver cirrhosis.
  • Further research into empirical treatments for cirrhotic cardiomyopathy is warranted.